APPROVED CHAPTER
JUNE 11, 2021 161
BY GOVERNOR PUBLIC LAW
STATE OF MAINE
_____
IN THE YEAR OF OUR LORD
TWO THOUSAND TWENTY-ONE
_____
H.P. 984 - L.D. 1333
An Act Concerning the Controlled Substances Prescription Monitoring
Program and the Dispensing of Naloxone Hydrochloride by Emergency
Medical Services Providers
Emergency preamble. Whereas, acts and resolves of the Legislature do not
become effective until 90 days after adjournment unless enacted as emergencies; and
Whereas, an increasing number of residents of Maine are dying as a result of opioid-
related overdoses; and
Whereas, increasing naloxone hydrochloride distribution is critical to saving lives;
and
Whereas, in the judgment of the Legislature, these facts create an emergency within
the meaning of the Constitution of Maine and require the following legislation as
immediately necessary for the preservation of the public peace, health and safety; now,
therefore,
Be it enacted by the People of the State of Maine as follows:
Sec. 1. 22 MRSA §2353, sub-§2-A is enacted to read:
2-A. Dispensing of naloxone hydrochloride by emergency medical services
persons, ambulance services and nontransporting emergency medical services.
Notwithstanding any provision of law to the contrary, pursuant to a standing order issued
in accordance with protocols developed by the Medical Direction and Practices Board
pursuant to Title 32, section 88-B, subsection 1, paragraph A, an emergency medical
services person, ambulance service or nontransporting emergency medical service licensed
under Title 32, chapter 2-B may dispense naloxone hydrochloride to an individual of any
age at risk of experiencing an opioid-related drug overdose or to a member of the
individual's immediate family, a friend of the individual or another person in a position to
assist the individual if the individual is at risk of experiencing an opioid-related drug
overdose.
Sec. 2. 22 MRSA §7250, sub-§4, ¶K, as amended by PL 2017, c. 213, §6, is further
amended to read:
Page 1 - 130LR1889(03)
 K. The chief medical officer, medical director or other administrative prescriber
employed by a licensed hospital, insofar as the information relates to prescriptions
written by prescribers employed by that licensed hospital; and
Sec. 3. 22 MRSA §7250, sub-§4, ¶K-1 is enacted to read:
K-1. The chief medical officer, medical director or other administrative prescriber
employed by a federally qualified health center as defined in 42 United States Code,
Section 1395x, subsection (aa) (1993) or a group practice of prescribers insofar as the
information relates to prescriptions written by prescribers employed by the federally
qualified health center or the group practice; and
Sec. 4. 32 MRSA §85, sub-§8 is enacted to read:
8. Naloxone hydrochloride. An emergency medical services person licensed under
this chapter may dispense naloxone hydrochloride in accordance with Title 22, section
2353, subsection 2-A and the rules adopted and protocols developed for emergency medical
services persons under this chapter.
Sec. 5. 32 MRSA §86, sub-§4 is enacted to read:
4. Naloxone hydrochloride. An ambulance service or a nontransporting emergency
medical service licensed under this chapter may dispense naloxone hydrochloride in
accordance with Title 22, section 2353, subsection 2-A and the rules adopted and protocols
developed for ambulance services and nontransporting emergency medical services under
this chapter.
Emergency clause. In view of the emergency cited in the preamble, this legislation
takes effect when approved.
Page 2 - 130LR1889(03)


Statutes affected:
Bill Text LD 1333, HP 984: 22.2353
Bill Text ACTPUB , Chapter 161: 22.7250